For Treatment Value, Imatinib Remains the CML Gold Standard

A generic second-generation TKI is needed to help improve treatment-free remission rates.
Medscape Medical News

source https://www.medscape.com/viewarticle/choose-best-first-line-drug-cml-consider-efficacy-and-cost-2024a1000g51?src=rss